L awsonia intracellularis is a highly fastidious, obligate intracellular Gram-negative bacterium (7) that is one of the most prevalent enteric pathogens of pigs, causing acute intestinal hemorrhaging (proliferative hemorrhagic enteropathy [PHE]) in naïve adult pigs and a wasting disease (porcine intestinal adenomatosis [PIA]) in growing pigs (5). In vitro culture of L. intracellularis is only possible via cocultivation with certain cell lines (4, 6). Mycoplasma contamination is a serious problem because the widely used method to passage L. intracellularis cultures is based on techniques to concentrate bacteria that are extracted from infected cell monolayers (3, 6) . During the routine cultivation of L. intracellularis in the laboratory, the authors found that (i) in Mycoplasmacontaminated cell cultures, Mycoplasma was inevitably concentrated with L. intracellularis, (ii) the growth of L. intracellularis was inhibited by Mycoplasma contamination, and (iii) L. intracellularis was eventually lost from the culture. Mycoplasma was also concentrated during the passaging of L. intracellularis, inducing cytopathic changes, including the death of cells required for the sustained growth of L. intracellularis. This report describes Mycoplasma contamination of L. intracellularis cultures that led to the unintended acquisition of a monoclonal antibody against Mycoplasma spp. during the attempted generation of a monoclonal antibody against L. intracellularis.
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A strain of L. intracellularis, PIA/MyCoyL1 (Animal, Plant, and Fisheries Quarantine and Inspection Agency [QIA], Republic of Korea), was used to generate a monoclonal antibody. Briefly, McCoy cells were infected with an L. intracellularis suspension. The passage of infected cells was performed using a 0.1% KCl treatment followed by removal of infected cells from the flask using a cell scraper (6) . The scraped cells were ruptured by passing the infected cells six times through a 20-gauge needle. The resulting bacterial suspension was used to infect fresh McCoy cells in 25-cm 2 flasks. Infected McCoy cells were harvested on a weekly basis using the aforementioned technique to maintain the L. intracellularis culture. The bacterial suspensions were stored at 4°C until they were used to challenge BALB/c mice later in the same day. The mice were primed and boosted twice every 3 weeks with an extracted L. intracellularis suspension combined with Freund's adjuvant (Sigma-Aldrich, St. Louis, MO). To generate hybridomas, spleen cells were harvested 3 days after the intravenous boost and fused with SP2/O myeloma cells using polyethylene glycol. The immunoperoxidase monolayer assay (IPMA) was used to screen the supernatant from hybridoma subclones. For the IPMA, the L. intracellularis culture plate (or slide) was fixed, incubated with the supernatant from the hybridoma subclones for 30 min at 37°C, and washed 5 times with phosphate-buffered saline (PBS) (pH 7.2). Horseradish peroxidase (HRP)-conjugated rabbit anti-mouse IgG was diluted 1:600 in 1% bovine serum albumin (BSA) in PBS and added at a concentration of 30 l/well. The plate was incubated for 45 min at 37°C and then washed, and a chromogen (3-amino-9-ethyl-carbazole) solution was added to each well. The plate was then incubated at room temperature for 20 min. The plate was washed with distilled water 3 times, allowed to dry, and examined using an inverted light microscope. L. intracellularis-positive and -negative antisera were included on each plate as controls. The positive hybridoma subclones were preliminarily chosen based on IPMA staining data that matched those typically observed (6) with L. intracellularis-positive antisera (Fig. 1A) . Several dozen monoclonal antibodies that targeted L. intracellularis were developed. However, two typically different patterns-one pattern characteristic for L. intracellularis and one pattern characteristic for Mycoplasma spp.-were observed using supernatants from some hybridoma subclones. Many of the granules were aggregates composed of several smaller particles in IPMA-stained L. intracellularis culture plates (Fig. 1B) . The particles were irregularly shaped, small, and round. In contrast, the L. intracellularis particles were regular, large, and rodlike. We found that there was an accidental contamination of the inoculum used to immunize mice during the monoclonal antibody production process. We presumed that one hybridoma (F9) culture produced a monoclonal antibody of the IgG2b isotype against Mycoplasma spp. A species-specific PCR assay that targeted a presumed mollicute-specific sequence of the 16S rRNA gene of Mycoplasma spp. was used as previously described (10) , and the amplified PCR product was sequenced. Importantly, the immunohistochemistry test using the F9 monoclonal antibody and the species-specific PCR assay enabled the labeled granules observed by light micros-copy to be identified as morphologically distinct organisms, a result which allowed us to more confidently conclude that the granules detected under bright-field conditions were from Mycoplasma spp. This F9 antibody was finally identified as a monoclonal antibody against Mycoplasma hyorhinis by using an immunohistochemistry test for Mycoplasma spp. in a cell culture and sequencing analysis.
The detection of other contaminating Mycoplasma species, such as Mycoplasma orale and Mycoplasma fermentans, in L. intracellularis cultures stored in our laboratory was also possible with the IPMA method and the monoclonal antibody produced in this study. The monoclonal antibody reacted with 12 species of Mycoplasma (ATCC) which exhibited the staining pattern characteristic of Mycoplasma spp. The detection of 12 other Mycoplasma species, such as M. orale and M. fermentans, was also possible using the immunofluorescence staining method. However, this antibody did not react with Mycoplasma-free McCoy cells. Nonspecific staining was also not observed when this antibody was tested on other cell lines, such as Vero, RK13, and IEC-18 cells ( Table 1 ). The specific advantages of a monoclonal antibodybased technique for the identification of Mycoplasma spp. include the ease of visualization under bright-field conditions without the UV light required to observe PCR products and the ability to gauge the level of Mycoplasma contamination in L. intracellularis cultures. The monoclonal antibody (250 to 1,000 ng/reaction) used in this study did not neutralize or inhibit the Mycoplasma species present in the 29 contaminated L. intracellularis cultures stored in our laboratory. A previous study reported that immunological methods are of limited value for Mycoplasma neutralization because Mycoplasma species are not entirely eliminated but merely suppressed (low efficiency) (11) .
The rapid identification of Mycoplasma-contaminated cell cultures and materials enables a faster response to prevent the spread of contamination in L. intracellularis cell cultures. Although there are many reports of monoclonal antibodies against clinical isolates of Mycoplasma spp. from human and animal specimens, information on monoclonal antibodies against Mycoplasma spp. in contaminated cell cultures is limited in peer-reviewed publications (1, 2, 8, 9) . The immunostaining assay using this monoclonal 
